Recombinant clotting factors are artificially produced proteins that help in blood clotting. They are synthesized through recombinant DNA technology, which allows for the manufacturing of these proteins in a controlled environment. These factors are essential in the management of bleeding disorders, especially in patients who have deficiencies or dysfunctions in their natural clotting factors.
